Mass spectrometric serum markers of colorectal cancer

被引：0
|
作者：
Stedronsky, Katrin [1 ]
Zhang, Yilan [1 ]
Barker, Douglas S. [1 ]
机构：
[1] Miraculins Inc, Res & Dev, Winnipeg, MB, Canada
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2006年 / 101卷 / 09期
关键词：
D O I：
10.14309/00000434-200609001-00525
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
525
引用
收藏
页码：S221 / S221
页数：1
相关论文
共 50 条
  • [41] Molecular Markers for Colorectal Cancer
    Wright, Moriah
    Beaty, Jenifer S.
    Ternent, Charles A.
    SURGICAL CLINICS OF NORTH AMERICA, 2017, 97 (03) : 683 - +
  • [42] Development of quantitative mass spectrometric immunoassay for serum amyloid A
    Trenchevska, Olgica
    Yassine, Hussein N.
    Borges, Chad R.
    Nelson, Randall W.
    Nedelkov, Dobrin
    BIOMARKERS, 2016, 21 (08) : 743 - 751
  • [43] Mass spectrometric identification, characterization and validation of the haptoglobin β-chain protein as a lung cancer serum biomarker
    Ayyub, Asima
    Saleem, Mahjabeen
    Musharraf, Syed Ghulam
    Naz, Mamoona
    Tariq, Asma
    Hashmi, Naghma
    MOLECULAR MEDICINE REPORTS, 2015, 12 (03) : 3755 - 3762
  • [44] An intelligent decision support algorithm for diagnosis of colorectal cancer through serum tumor markers
    Shi, Jinghua
    Su, Qiang
    Zhang, Chenpeng
    Huang, Gang
    Zhu, Yan
    COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE, 2010, 100 (02) : 97 - 107
  • [45] Simultaneous Multianalyte Immunoassay Measurement of Five Serum Tumor Markers in the Detection of Colorectal Cancer
    Lumachi, Franco
    Marino, Filippo
    Orlando, Rocco
    Chiara, Giordano B.
    Basso, Stefano M. M.
    ANTICANCER RESEARCH, 2012, 32 (03) : 985 - 988
  • [46] Serum PlGF and EGF are independent prognostic markers in non-metastatic colorectal cancer
    Sebastian Schölch
    Andreas Bogner
    Ulrich Bork
    Mohammad Rahbari
    Balázs Győrffy
    Martin Schneider
    Christoph Reissfelder
    Jürgen Weitz
    Nuh N. Rahbari
    Scientific Reports, 9
  • [47] The combined use of serum neurotensin and IL-8 as screening markers for colorectal cancer
    Sgourakis, George
    Papapanagiotou, Aggeliki
    Kontovounisios, Christos
    Karamouzis, Michalis V.
    Dedemadi, Georgia
    Goumas, Constantine
    Karaliotas, Constantine
    Papavassiliou, Athanasios G.
    TUMOR BIOLOGY, 2014, 35 (06) : 5993 - 6002
  • [48] VALUE OF SERUM ASSAY OF TUMOR-MARKERS FOR THE DETECTION OF COLORECTAL-CANCER RECURRENCES
    PELISSIER, E
    BOSSET, JF
    MENEVEAU, N
    BULLETIN DU CANCER, 1994, 81 (12) : 1050 - 1056
  • [49] Identification and validation of novel serum tumour markers for colorectal cancer applying proteomics approaches
    Roessler, M.
    Rollinger, W.
    Thierolf, M.
    Wild, N.
    Hagmann, M. L.
    Rueschoff, J.
    Rohr, G.
    Rossol, S.
    Roesch, W.
    Tacke, M.
    EJC SUPPLEMENTS, 2007, 5 (04): : 245 - 245
  • [50] Serum endostatin levels are elevated in colorectal cancer and correlate with invasion and systemic inflammatory markers
    Kantola, T.
    Vayrynen, J. P.
    Klintrup, K.
    Makela, J.
    Karppinen, S. M.
    Pihlajaniemi, T.
    Autio-Harmainen, H.
    Karttunen, T. J.
    Makinen, M. J.
    Tuomisto, A.
    BRITISH JOURNAL OF CANCER, 2014, 111 (08) : 1605 - 1613
12345